034940 — ChoA Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapSucker Stock

Annual cashflow statement for ChoA Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-1,606	-8,043	515	-11,133	-10,168
Depreciation
Amortisation
Non-Cash Items	3,494	4,641	1,840	7,618	4,397
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-3,016	-973	-6,187	-347	-1,086
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	1,922	-1,480	-1,443	-1,475	-4,468
Capital Expenditures	-3,641	-3,864	-2,922	-943	-780
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-396	1,998	1,369	1,674	-1,022
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-4,037	-1,866	-1,553	731	-1,802
Financing Cash Flow Items	-168	101	11.5	-27.2	-32
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-3,832	4,825	1,807	-1,690	6,192
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-5,873	1,585	-1,223	-2,478	50